Access cutting-edge b-cell lymphoma treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access b-cell lymphoma specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related b-cell lymphoma treatment provided free
Study consists of two main parts to explore BGB-16673 recommended dosing, a Phase 1 monotherapy dose finding comprised of monotherapy dose escalation and monotherapy safety expansion of selected doses, and a Phase 2 (expansion cohorts)
Sponsor: BeiGene
Check if you qualify for this b-cell lymphoma clinical trial in Phoenix, AZ
If you're searching for b-cell lymphoma treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced b-cell lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.